Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Foot-and-mouth disease is a highly contagious and severe disease that affects cattle, sheep, swine, and other cloven-hoofed ...

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

On U.S. dairy operations, mastitis remains the costliest disease, driven by expenses for antibiotic treatments and losses in ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...

There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

A 65-year-old woman presents for an evaluation of fatigue, which she has had for at least the past 3 months.The medical ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure—affecting more than 250 million people worldwide—Echosens, ...